Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription Articles published in J Mol Cell Cardiol Retrieve available abstracts of 59 articles: HTML format

Single Articles

September 2026
1. KASSAB S, Albalawi Z, Khojah AM, Stonall CD, et al
   Loss of Miro1 drives cardiac and mitochondrial dysfunction exacerbated by metabolic stress.
   J Mol Cell Cardiol. 2026;218:157-173.
   PubMed     Abstract available
   
   
   
2. KOBAK KA, Zarzycka W, King CJ, Peelor FF 3rd, et al
   Cardiometabolic stress induces HFpEF with impaired bioenergetics and disrupted proteostasis in aged female mice.
   J Mol Cell Cardiol. 2026;218:151-156.
   PubMed     Abstract available
   
   
   August 2026
3. ZHAO W, Li Q, Chen H, Jiang R, et al
   The Deubiquitinase OTUD5 regulates cardiac hypertrophy by stabilizing TNF receptor associated factor 2.
   J Mol Cell Cardiol. 2026;217:163-175.
   PubMed     Abstract available
   
   
   July 2026
4. KAGAMI K, Nagatomo Y, Toya T, Yumita Y, et al
   Cell-specific ERK2 signaling in vascular smooth muscle cells drives vascular dysfunction and systolic heart failure.
   J Mol Cell Cardiol. 2026 Jul 28:S0022-2828(26)00118.
   PubMed     Abstract available
   
   
   
5. LEE A, Oh JG, Mitsuyama S, Wang H, et al
   A metabolically stable second-generation SERCA2a SUMOylation enhancer improves cardiac function in heart failure.
   J Mol Cell Cardiol. 2026;218:55-66.
   PubMed     Abstract available
   
   
   
6. HAMILTON S, Terentyeva R, Veress R, Perger F, et al
   Restoration of mitochondrial Ca(2+) and redox homeostasis by enhancement of SK channels rescues Ca(2+) cycling in HFpEF cardiomyocytes.
   J Mol Cell Cardiol. 2026;216:1-12.
   PubMed     Abstract available
   
   
   June 2026
7. TADOKORO T, Liu N, Olson EN
   Precision modification of heart failure signaling by CRISPR-Cas9 base editing.
   J Mol Cell Cardiol. 2026 Jun 19:S0022-2828(26)00092.
   PubMed     Abstract available
   
   
   May 2026
8. ZHOU H, Christopher CJ, Jones K, Pla MM, et al
   Myocardial metabolic remodeling in human end-stage ischemic and non-ischemic cardiomyopathy.
   J Mol Cell Cardiol. 2026;214:17-27.
   PubMed     Abstract available
   
   
   April 2026
9. YANG X, Kawasaki NK, Min J, Matsui T, et al
   Corrigendum to "Ferroptosis in heart failure" [Journal of Molecular and Cellular Cardiology, Volume 173 (2022) Pages 141-153].
   J Mol Cell Cardiol. 2026;215:51.
   PubMed    
   
   
   
10. PITOULIS F, Pamias-Lopez B, Bedi K, Cheng L, et al
    Junctophilin-2 abundance is unaltered in human heart failure samples with disrupted T-tubules and contractility.
    J Mol Cell Cardiol. 2026;215:1-5.
    PubMed     Abstract available
    
    
    January 2026
11. LI M, Wang Y, Widdop RE
    Novel angiotensin receptor target as therapy for the diabetic heart: the AT(2)R.
    J Mol Cell Cardiol. 2026;210:83-97.
    PubMed     Abstract available
    
    
    November 2025
12. MILLER JA, Moise N, Mendez MJ, Weinberg SH, et al
    Interplay between variability in intrinsic cellular properties and heart failure-associated remodeling in a simulated population with human heart failure.
    J Mol Cell Cardiol. 2025 Nov 18:S0022-2828(25)00212.
    PubMed     Abstract available
    
    
    
13. ZHANG M, Chen C, Liu X, Zhou Z, et al
    Soluble epoxide hydrolase deficiency rescues heart failure with preserved ejection fraction by targeting cytochrome P450 2E1.
    J Mol Cell Cardiol. 2025;210:98-108.
    PubMed     Abstract available
    
    
    October 2025
14. SHUMLIAKIVSKA M, Fischer A, Muhly-Reinholz M, Leonard VE, et al
    The long non-coding RNA Snhg15 protects the heart after myocardial infarction.
    J Mol Cell Cardiol. 2025 Oct 27:S0022-2828(25)00195.
    PubMed     Abstract available
    
    
    
15. PAULS P, Fabritz L, Herting JR, Johann A, et al
    Catecholaminergic stress results in signs of heart failure in PP2A-PR72 overexpressor mice.
    J Mol Cell Cardiol. 2025;209:66-79.
    PubMed     Abstract available
    
    
    September 2025
16. CHEN D, Sindone A, Huang MLH, Peter K, et al
    Diabetic cardiomyopathy: insights into pathophysiology, diagnosis and clinical management.
    J Mol Cell Cardiol. 2025;206:55-69.
    PubMed     Abstract available
    
    
    April 2025
17. SPAGNOL G, Trease A, Zheng L, Sobota S, et al
    Cx45 regulation by kinases and impact of expression in heart failure.
    J Mol Cell Cardiol. 2025;203:91-105.
    PubMed     Abstract available
    
    
    
18. MCLENDON JM, Zhang X, Stein CS, Baehr LM, et al
    Gain and loss of the centrosomal protein taxilin-beta influences cardiac proteostasis and stress.
    J Mol Cell Cardiol. 2025;201:56-69.
    PubMed     Abstract available
    
    
    
19. SMOLGOVSKY S, Bayer AL, Aronovitz M, Vanni KMM, et al
    Experimental pressure overload induces a cardiac neoantigen specific humoral immune response.
    J Mol Cell Cardiol. 2025;201:87-93.
    PubMed     Abstract available
    
    
    March 2025
20. ROBERTS TD, Hutchinson DS, Wootten D, De Blasio MJ, et al
    Advances in incretin therapies for targeting cardiovascular disease in diabetes.
    J Mol Cell Cardiol. 2025;202:102-115.
    PubMed     Abstract available
    
    
    
21. CHEN Z, Zhong M, Lin Y, Zhang W, et al
    METTL7B-induced histone lactylation prevents heart failure by ameliorating cardiac remodelling.
    J Mol Cell Cardiol. 2025 Mar 9:S0022-2828(25)00046.
    PubMed     Abstract available
    
    
    February 2025
22. GUAN J, Fefelova N, Zhai P, Ikeda Y, et al
    Dual inhibition of Mst1 and Mst2 exacerbates cardiac dysfunction during pressure overload stress in mice.
    J Mol Cell Cardiol. 2025;199:133-136.
    PubMed     Abstract available
    
    
    January 2025
23. SHABANI P, Dong F, Yun J, Shin SY, et al
    Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?
    J Mol Cell Cardiol. 2025 Jan 28:S0022-2828(25)00007.
    PubMed     Abstract available
    
    
    December 2024
24. KASS DA
    Assessing and interpreting diastolic function in animal models of heart disease.
    J Mol Cell Cardiol. 2024;197:1-4.
    PubMed     Abstract available
    
    
    November 2024
25. KATTIH B, Fischer A, Muhly-Reinholz M, Tombor L, et al
    Inhibition of miR-92a normalizes vascular gene expression and prevents diastolic dysfunction in heart failure with preserved ejection fraction.
    J Mol Cell Cardiol. 2024 Nov 24:S0022-2828(24)00194.
    PubMed     Abstract available
    
    
    
26. FU J, Li L, Chen L, Su C, et al
    Corrigendum to "PGE2 protects against heart failure through inhibiting TGF-beta1 synthesis in cardiomyocytes and crosstalk between TGF-beta1 and GRK2" [Journal of Molecular and Cellular Cardiology. 172(2022) 63-77].
    J Mol Cell Cardiol. 2024 Nov 22:S0022-2828(24)00191.
    PubMed    
    
    
    
27. ABBAS N, Bentele M, Waleczek FJG, Fuchs M, et al
    Ex vivo modelling of cardiac injury identifies ferroptosis-related pathways as a potential therapeutic avenue for translational medicine.
    J Mol Cell Cardiol. 2024;196:125-140.
    PubMed     Abstract available
    
    
    
28. ZERVOU S, McAndrew DJ, Lake HA, Kuznecova E, et al
    Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity.
    J Mol Cell Cardiol. 2024;196:105-114.
    PubMed     Abstract available
    
    
    October 2024
29. JANI VP, Koleini N, Fenwick AJ, Sharp TE, et al
    Cardiomyocyte myofilament function in common animal models of heart failure with preserved ejection fraction.
    J Mol Cell Cardiol. 2024 Oct 18:S0022-2828(24)00166.
    PubMed     Abstract available
    
    
    
30. BEITO M, Taegtmeyer H
    Metabolic cycles: A unifying concept for energy transfer in the heart.
    J Mol Cell Cardiol. 2024;195:103-109.
    PubMed     Abstract available
    
    
    
31. FAN D, Wu R
    Mechanisms of the septic heart: From inflammatory response to myocardial edema.
    J Mol Cell Cardiol. 2024;195:73-82.
    PubMed     Abstract available
    
    
    
32. KAPLAN AD, Boyman L, Ward CW, Lederer WJ, et al
    Ryanodine receptor stabilization therapy suppresses Ca(2+)- based arrhythmias in a novel model of metabolic HFpEF.
    J Mol Cell Cardiol. 2024;195:68-72.
    PubMed     Abstract available
    
    
    August 2024
33. WALKER MA, Tian R
    NAD metabolism and heart failure: Mechanisms and therapeutic potentials.
    J Mol Cell Cardiol. 2024;195:45-54.
    PubMed     Abstract available
    
    
    July 2024
34. CANTRELL AC, Besanson J, Williams Q, Hoang N, et al
    Ferrostatin-1 specifically targets mitochondrial iron-sulfur clusters and aconitase to improve cardiac function in Sirtuin 3 cardiomyocyte knockout mice.
    J Mol Cell Cardiol. 2024;192:36-47.
    PubMed     Abstract available
    
    
    
35. LAHIRI SK, Lu J, Aguilar-Sanchez Y, Li H, et al
    Targeting Calpain-2-mediated Junctophilin-2 cleavage delays heart failure progression following myocardial infarction.
    J Mol Cell Cardiol. 2024 Jul 1:S0022-2828(24)00108.
    PubMed     Abstract available
    
    
    April 2024
36. CHOKSEY A, Carter RD, Thackray BD, Ball V, et al
    AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats.
    J Mol Cell Cardiol. 2024;191:12-22.
    PubMed     Abstract available
    
    
    March 2024
37. NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al
    Promoting cardiomyocyte proliferation for myocardial regeneration in large mammals.
    J Mol Cell Cardiol. 2024;188:52-60.
    PubMed     Abstract available
    
    
    February 2024
38. ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
    Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
    J Mol Cell Cardiol. 2024;189:1-11.
    PubMed     Abstract available
    
    
    
39. SOMA Y, Tani H, Morita-Umei Y, Kishino Y, et al
    Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    J Mol Cell Cardiol. 2024;187:90-100.
    PubMed     Abstract available
    
    
    
40. SAKAMOTO T, Kelly DP
    Cardiac maturation.
    J Mol Cell Cardiol. 2024;187:38-50.
    PubMed     Abstract available
    
    
    January 2024
41. SHI L, Li X, Zhang M, Qin C, et al
    Downregulation of Wtap causes dilated cardiomyopathy and heart failure.
    J Mol Cell Cardiol. 2024 Jan 13:S0022-2828(24)00002.
    PubMed     Abstract available
    
    
    
42. SHINTANI Y, Fukushima S, Varela-Carver A, Lee J, et al
    Corrigendum to "Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure" [J Mol Cell Cardiol 47 (2009) 288-295].
    J Mol Cell Cardiol. 2024 Jan 10:S0022-2828(24)00001.
    PubMed    
    
    
    
43. CHU Y, Hua Y, He L, He J, et al
    beta-hydroxybutyrate administered at reperfusion reduces infarct size and preserves cardiac function by improving mitochondrial function through autophagy in male mice.
    J Mol Cell Cardiol. 2024;186:31-44.
    PubMed     Abstract available
    
    
    November 2023
44. MANGIONE MC, Wen J, Cao DJ
    Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases.
    J Mol Cell Cardiol. 2023;186:111-124.
    PubMed     Abstract available
    
    
    
45. CHEN S, Wang K, Wang J, Chen X, et al
    Profiling cardiomyocytes at single cell resolution reveals COX7B could be a potential target for attenuating heart failure in cardiac hypertrophy.
    J Mol Cell Cardiol. 2023;186:45-56.
    PubMed     Abstract available
    
    
    October 2023
46. WADDELL HMM, Mereacre V, Alvarado FJ, Munro ML, et al
    Clustering properties of the cardiac ryanodine receptor in health and heart failure.
    J Mol Cell Cardiol. 2023;185:38-49.
    PubMed     Abstract available
    
    
    
47. ZHAO C, Jiang X, Peng L, Zhang Y, et al
    Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.
    J Mol Cell Cardiol. 2023;185:13-25.
    PubMed     Abstract available
    
    
    
48. MENASCHE P
    Human PSC-derived cardiac cells and their products: therapies for cardiac repair.
    J Mol Cell Cardiol. 2023;183:14-21.
    PubMed     Abstract available
    
    
    
49. PALIOURA D, Mellidis K, Ioannidou-Kabouri K, Galatou E, et al
    PPARdelta activation improves cardiac mitochondrial homeostasis in desmin deficient mice but does not alleviate systolic dysfunction.
    J Mol Cell Cardiol. 2023;183:27-41.
    PubMed     Abstract available
    
    
    September 2023
50. LIU Z, Liu Z, Xu X, Zhou Y, et al
    Role of ventrolateral part of ventromedial hypothalamus in post-myocardial infarction cardiac dysfunction induced by sympathetic nervous system.
    J Mol Cell Cardiol. 2023 Sep 30:S0022-2828(23)00154.
    PubMed     Abstract available
    
    
    
51. PEZHOUMAN A, Nguyen NB, Kay M, Kanjilal B, et al
    Cardiac regeneration - Past advancements, current challenges, and future directions.
    J Mol Cell Cardiol. 2023;182:75-85.
    PubMed     Abstract available
    
    
    August 2023
52. KMIETCZYK V, Oelschlager J, Gupta P, Varma E, et al
    Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.
    J Mol Cell Cardiol. 2023;181:57-66.
    PubMed     Abstract available
    
    
    July 2023
53. KOBAYASHI S, Yamamoto T, Yano M
    RyR2-stabilization therapy with dantrolene against left ventricular remodeling and lethal arrhythmia in heart failure.
    J Mol Cell Cardiol. 2023 Jul 5:S0022-2828(23)00108.
    PubMed    
    
    
    June 2023
54. MONTANES-AGUDO P, Pinto YM, Creemers EE
    Splicing factors in the heart: Uncovering shared and unique targets.
    J Mol Cell Cardiol. 2023;179:72-79.
    PubMed     Abstract available
    
    
    May 2023
55. YAMADA Y, Sadahiro T, Ieda M
    Development of direct cardiac reprogramming for clinical applications.
    J Mol Cell Cardiol. 2023;178:1-8.
    PubMed     Abstract available
    
    
    April 2023
56. MEHDIPOUR M, Park S, Huang GN
    Unlocking cardiomyocyte renewal potential for myocardial regeneration therapy.
    J Mol Cell Cardiol. 2023;177:9-20.
    PubMed     Abstract available
    
    
    
57. LI R, Xiang C, Li Y, Nie Y, et al
    Targeting immunoregulation for cardiac regeneration.
    J Mol Cell Cardiol. 2023;177:1-8.
    PubMed     Abstract available
    
    
    March 2023
58. GARRY GA, Olson EN
    Reprogramming of cardiac cell fate as a therapeutic strategy for ischemic heart disease.
    J Mol Cell Cardiol. 2023 Mar 28:S0022-2828(23)00058.
    PubMed     Abstract available
    
    
    
59. FUJII S, Kobayashi S, Chang Y, Nawata J, et al
    RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
    J Mol Cell Cardiol. 2023 Mar 22:S0022-2828(23)00052.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum